Latest Breaking News On - குறி ஹெகார்டி - Page 1 : comparemela.com

ClinSpec Diagnostics reaches funding target of £3.5m 5th March 2021 Glasgow-based ClinSpec Diagnostics has secured an additional £1.1m investment, reaching its round two funding target of £3.5m. ClinSpec, a spin-out company from the University of Strathclyde’s Department of Pure and Applied Chemistry, is aiming to develop liquid biopsies for the early detection of cancer. The new £1.1m investment from the latest funding round comes from a range of investors, including Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders. The first £2.4m was secured in 2020, with that funding round led by Mercia’s EIS Funds with Scottish Enterprise, SIS Ventures, Eos Advisory and the University of Strathclyde.

Mark hegartyNorcliffe capitalUniversity of strathclydeUniversity of strathclyde department pureGlasgow based clinspec diagnosticsApplied chemistryNorcliffe capital limitedNeos advisoryScottish enterpriseClinspec diagnosticsLiquid biopsyCancer detectionFunding roundகுறி ஹெகார்டிபயன்படுத்தப்பட்டது வேதியியல்ஸ்காட்டிஷ் நிறுவன